First day of trading in Capio’s shares


NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE
SERVICES OR PUBLICATION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN,
NEW ZEALAND, SOUTH AFRICA, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN
WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL
Capio AB (publ) (“Capio”), today announces the outcome of the offer to acquire
shares in the company (the “Offering”). Trading in Capio’s shares begins today,
30 June 2015. The Offering attracted very strong interest from both Swedish and
international institutions as well as the general public in Sweden. The Offering
was substantially over-subscribed.

The offering in brief

As previously announced, the price at the Offering was SEK 48.5 per share,
corresponding to a market value of all shares in Capio of approximately SEK
6,846 million

  · The Offering comprised 48,122,611 of Capio’s shares, corresponding to
approximately 34.1 percent of the total number of shares in Capio after
completion of the Offering, of which 15,463,918 newly issued shares and
32,658,693 existing shares were sold by Ygeia Equity AB, a company owned by
Nordic Capital Fund VI (“Nordic Capital”), the Apax Europe VI fund (advised by
Apax Partners LLP) (“Apax Partners”) and the Apax France VII fund (managed by
Apax Partners S.A, “Apax France”)

  · In accordance with the terms of the offering, Ygeia Equity AB has also
granted to the Joint Global Coordinators the option to procure purchasers for up
to an additional 4,812,261 shares in the Offering (the “Overallotment option”)
[1]

  · Assuming that the Overallotment option is fully exercised, the Offering will
comprise a total of 52,934,872 shares, corresponding to approximately 37.5
percent of all shares in Capio after completion of the Offering, and the total
value of the Offering will amount to SEK 2,567 million

  · As a result of the Offering, Capio now has more than 5,000 new shareholders

  · R12 Kapital AB (the af Jochnick family), the Fourth Swedish National Pension
Fund, Swedbank Robur Fonder and Handelsbanken Fonder have, on the same
conditions as other investors, acquired shares in the Offering corresponding to
6.2 percent, 5.5 percent, 5.5 percent and 3.2 percent, respectively, of the
total number of shares in Capio after completion of the Offering

  · Trading in Capio’s shares on Nasdaq Stockholm commences today, 30 June 2015,
with the ticker symbol ”CAPIO”

[1] The Overallotment option can be exercised, in whole or in part, on one or
more occasions, by SEB as responsible for any stabilisation measures

Advisors
J.P. Morgan and SEB are acting as Joint Global Coordinators and Joint
Bookrunners. Carnegie and Deutsche Bank are acting as Joint Bookrunners.
Rothschild is acting as financial advisor to Capio and certain shareholders.
Mannheimer Swartling and Davis Polk are acting as legal advisers to Capio and
the Selling Shareholder.

For information, please contact:
Thomas Berglund, President and CEO, Capio
Phone: +46 73 388 8600
Email: thomas.berglund@capio.com

Henrik Brehmer, SVP Corporate Communications and Public Affairs, Capio
Phone: +46 76 111 3414
Email: henrik.brehmer@capio.com

About Capio
Capio is a leading, pan-European healthcare provider offering a broad range of
high quality medical, surgical and psychiatric healthcare services in four
countries through its hospitals, specialist clinics and primary care units. In
2014, Capio’s 12,357 employees provided healthcare services during 4.6 million
patient visits across the Group’s facilities in Sweden, Norway, France and
Germany, generating net sales of MSEK 13,200 [2]. Capio operates across three
geographic segments: Nordic (54 percent of Group net sales), France (37 percent
of Group net sales) and Germany (9 percent of Group net sales). For more
information about Capio, please see www.capio.com.

[2] Pro forma net sales after adjustments MSEK 12,960

Disclaimer
This announcement is not an offer to sell or a solicitation of any offer to buy
any securities issued by Capio AB (publ) (the "Company") in any jurisdiction
where such offer or sale would be unlawful.

In any EEA Member State, other than Sweden, that has implemented Directive
2003/71/EC as amended (together with any applicable implementing measures in any
member State, the “Prospectus Directive”), this communication is only addressed
to and is only directed at qualified investors in that Member State within the
meaning of the Prospectus Directive.

This announcement and the information contained herein are not for distribution
in or into the United States of America. This announcement does not constitute
an offer to sell, or a solicitation of an offer to purchase or subscribe for,
any securities in the United States. Any securities referred to herein have not
been and will not be registered under the U.S. Securities Act of 1933, as
amended (the “Securities Act”), and may not be offered or sold within the United
States absent registration or an applicable exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act. There is no
intention to register any securities referred to herein in the United States or
to make a public offering of the securities in the United States.

In the United Kingdom, this announcement and any other material in relation to
the shares described herein (the “Shares”) are being distributed only to, and
are directed only at, persons who are “qualified investors” (as defined in the
Prospectus Directive) who are (i) persons having professional experience in
matters relating to investments falling within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), or
(ii) high net worth entities falling within Article 49(2)(a) to (d) of the
Order, or (iii) persons to whom it would otherwise be lawful to distribute them,
all such persons together being referred to as “Relevant Persons”. The Shares
are only available to, and any invitation, offer or agreement to subscribe,
purchase or otherwise acquire such Shares will be engaged in only with, Relevant
Persons. This announcement should not be distributed, published or reproduced
(in whole or in part) or disclosed by any recipients to any other person in the
United Kingdom. Any person in the United Kingdom that is not a Relevant Person
should not act or rely on this announcement or its contents. The Shares are not
being offered to the public in the United Kingdom.

In connection with the Offering, SEB, as stabilising manager (the “Stabilising
Manager”), may carry out transactions aimed at supporting the market price of
the Shares at levels above those which might otherwise prevail in the open
market. Such stabilisation transactions may be effected on Nasdaq Stockholm, in
the over-the-counter market or otherwise, at any time during the period starting
on the date of commencement of trading in the Shares on Nasdaq Stockholm and
ending no later than 30 calendar days thereafter. The Stabilising Manager is,
however, not required to undertake any stabilisation and there is no assurance
that stabilisation will be undertaken. Stabilisation, if undertaken, may be
discontinued at any time without prior notice. In no event will transactions be
effected at levels above the price in the Offering. Within one week of the end
of the stabilisation period, the Stabilising Manager will make public whether or
not stabilisation was undertaken, the date at which stabilisation started, the
date at which stabilisation last occurred and the price range within which
stabilisation was carried out, for each of the dates during which stabilisation
transactions were carried out.

Any offering of the securities referred to in this communication will be made by
means of a prospectus that may be obtained from the Company and that will
contain detailed information about the Company and management, as well as
financial statements. This communication is an advertisement and not a
prospectus for the purposes of the Prospectus Directive. Investors should not
acquire any securities referred to in this communication except on the basis of
information contained in a prospectus.

Forward-Looking Statements

Matters discussed in this communication may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as “believe,” “expect,” “anticipate,”
“intend,” “may,” “plan,” “estimate,” “will,” “should,” “could,” “aim” or
“might,” or, in each case, their negative, or similar expressions. The forward
-looking statements in this release are based upon various assumptions, many of
which are based, in turn, upon further assumptions. Although the Company
believes that the expectations reflected in these forward-looking statements are
reasonable, it can give no assurances that they will materialize or prove to be
correct. Because these statements are based on assumptions or estimates and are
subject to risks and uncertainties, the actual results or outcome could differ
materially from those set out in the forward-looking statements as a result of
many factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this release by such forward-looking statements. The
Company does not guarantee that the assumptions underlying the forward‐looking
statements in this presentation are free from errors nor does it accept any
responsibility for the future accuracy of the opinions expressed in this
presentation or any obligation to update or revise the statements in this
presentation to reflect subsequent events. Undue reliance should not be placed
on the forward-looking statements in this communication. The information,
opinions and forward-looking statements contained in this communication speak
only as at its date, and are subject to change without notice. The Company does
not undertake any obligation to review, update, confirm, or to release publicly
any revisions to any forward‐looking statements to reflect events that occur or
circumstances that arise in relation to the content of this communication.

Attachments

06297902.pdf
GlobeNewswire